Table 3.
Variables | Category | N | % |
---|---|---|---|
Parity (n=30) | 0 | 10 | 33.3 |
1 | 8 | 26.7 | |
≥2 | 12 | 40.0 | |
Symptoms (n=31) | Postcoital VB | 4 | 12.9 |
Vaginal discharge | 3 | 9.7 | |
Intermenstrual VB | 17 | 54.8 | |
Periodic hematuria | 1 | 3.2 | |
Abnormal Pap smear | 3 | 9.7 | |
Postmenopausal VB | 3 | 9.7 | |
Sites of carcinoma | Cervix | 22 | 61.1 |
Vagina | 10 | 27.8 | |
Cervix and vagina | 4 | 11.1 | |
*FIGO stage of cervical carcinoma (n=25) | Ⅰ | 13 | 52.0 |
Ⅱ | 9 | 36.0 | |
Ⅲ | 1 | 4.0 | |
Ⅳ | 2 | 8.0 | |
FIGO stage of vaginal carcinoma (n=10) | Ⅰ | 6 | 60.0 |
Ⅱ | 3 | 30.0 | |
Ⅲ | 1 | 10.0 | |
Pathology of cervix and vagina | Adenocarcinoma | 25 | 69.4 |
SCC | 10 | 27.8 | |
ASC | 1 | 2.8 | |
Urinary tract malformation | URA | 21 | 58.3 |
Others | 2 | 5.6 | |
No malformation | 13 | 36.1 | |
Genital tract malformation | HWWS | 8 | 22.2 |
Uterus didelphys | 17 | 47.2 | |
Others | 11 | 30.6 | |
Sites of carcinoma in patients with 2 cervices | One cervix | 9 | 45.0 |
(n=20) | Two cervices | 8 | 40.0 |
Vagina (no cervix) | 3 | 15.0 |
*1 carcinoma in situ was not included
Abbreviations: ASC, adenosquamous carcinoma; HWWS, Herlyn-Werner-Wunderlich syndrome; PUMCH, Peking Union Medical College Hospital; SCC, squamous-cell carcinoma; URA, unilateral renal agenesis; VB, vaginal bleeding